Results
1 -
10 of
14
(Click
here to explore results)
- Anti-fibrotic Drug Discovery, CHAPTER 1 TGFβ Signaling. Anne-Ulrike Trendelenburg
, 2020
, Pages 1-36
- Conference on Drug Design and Discovery Technologies, Evaluation of Cardiomyocyte Targeted Novel Nano-formulation of Pirfenidone on Doxorubicin Induced Congestive Heart Failure in Rats. M. Azamthulla, Dhrubojyoti Mukherjee, J. Roy, C. Ravishankar
, 2020
, Pages 212-218
- Anti-fibrotic Drug Discovery, CHAPTER 10 Intratumoral Fibrosis: Emerging Concepts and Therapeutic Opportunities. Viviana Cremasco, Jonathan Chang
, 2020
, Pages 259-306
- Anti-fibrotic Drug Discovery, CHAPTER 6 Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis. Andrew J. Thorley, Simon Krautwald, David J. Rowlands
, 2020
, Pages 165-184
- MALDI Mass Spectrometry Imaging: From Fundamentals to Spatial Omics, Chapter 14 MALDI Mass Spectrometry Imaging in Drug Discovery and Development. Jeremy A. Barry, Peter S. Marshall, M. Reid Groseclose
, 2022
, Pages 321-358
- Anti-fibrotic Drug Discovery, CHAPTER 2 Targeting the αv Integrins in Fibroproliferative Disease. C. B. Nanthakumar, R. J. D. Hatley, R. J. Slack
, 2020
, Pages 37-75
- Biomaterial Based Approaches to Study the Tumour Microenvironment, Chapter 15 Tissue-engineered Cancer Models in Drug Screening. R. Cao, A. Fomina, A. P. McGuigan
, 2023
, Pages 415-449
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 6 Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. Ssang-Goo Cho, Claude Hughes, Iyer Mahalaxmi, Mohana Devi Subramaniam, Balachandar Vellingiri, Stafford Warren
, 2022
, Volume 1
, Pages 136-164
- Kinase Drug Discovery, Subject Index
, 2012
, Pages 303-318
- Anti-fibrotic Drug Discovery, Subject Index
, 2020
, Pages 340-347